Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 13 years, Pharma Foods International Co's highest 3-Year average EPS without NRI Growth Rate was 125.40% per year. The lowest was -9.10% per year. And the median was 14.10% per year.
Pharma Foods International Co (TSE:2929) EPS (Diluted) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Pharma Foods International Co EPS (Diluted) Related Terms
Pharma Foods International Co EPS (Diluted) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Pharma Foods International Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharma Foods International Co PE Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pharma Foods International Co's PE Ratio distribution charts can be found below:
* The bar in red indicates where Pharma Foods International Co's PE Ratio falls into.
Pharma Foods International Co EPS (Diluted) Calculation
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-36.82
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharma Foods International Co (TSE:2929) has a EPS (Diluted) of 円-36.82 as of Jan. 2026. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Pharma Foods International Co and its competitors.
Is Pharma Foods International Co's EPS (Diluted) too high?
Pharma Foods International Co's current EPS (Diluted) is 円-36.82. Overall, Pharma Foods International Co has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Pharma Foods International Co's EPS (Diluted) compare to ZTS and UTHR?
Pharma Foods International Co's EPS (Diluted) of 円-36.82 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Drug Manufacturers company?
A good EPS (Diluted) depends on the Drug Manufacturers industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Pharma Foods International Co and its competitors. Pharma Foods International Co's current EPS (Diluted) is 円-36.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Foods International Co stock overvalued right now?
Based on GuruFocus' analysis, Pharma Foods International Co (TSE:2929) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,051.63, compared to a current price of 円588.00 — trading 44.1% below its estimated fair value. The current EPS (Diluted) is 円-36.82. Pharma Foods International Co's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Pharma Foods International Co (TSE:2929), the current EPS (Diluted) is 円-36.82 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharma Foods International Co (TSE:2929) Overvalued in 2026?
Based on GuruFocus' analysis, Pharma Foods International Co stock appears to be undervalued.
The current stock price of 円588.00 is trading 44.1% below its estimated GF Value™ of 円1,051.63.
GuruFocus considers Pharma Foods International Co to be Possible Value Trap.
Key valuation signals for TSE:2929:
EPS (Diluted): 円-36.82
GF Value™: 円1,051.63 vs. price of 円588.00 (44.1% below fair value)
No single metric tells the full story. See the TSE:2929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharma Foods International Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2929 has been successfully added to your 
